OS Therapies Inc's (NYSE:OSTX) Quiet Period To End on September 10th

OS Therapies' (NYSE:OSTX - Get Free Report) quiet period is set to expire on Tuesday, September 10th. OS Therapies had issued 1,600,000 shares in its initial public offering on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. During the company's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Analyst Upgrades and Downgrades

Separately, Brookline Capital Management raised OS Therapies to a "strong-buy" rating in a research report on Thursday, August 22nd.

OS Therapies Trading Down 4.3 %

Shares of NYSE:OSTX traded down $0.18 during trading on Tuesday, reaching $3.96. 84,323 shares of the stock traded hands, compared to its average volume of 386,810. OS Therapies has a 52-week low of $2.51 and a 52-week high of $4.90.

OS Therapies (NYSE:OSTX - Get Free Report) last posted its earnings results on Wednesday, August 14th. The company reported ($0.26) EPS for the quarter. Sell-side analysts expect that OS Therapies will post -0.47 EPS for the current year.

About OS Therapies

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.